|
|
|
Volumn 10, Issue 4, 2007, Pages 264-269
|
|
Lessons for the future: A review of sepsis past and present
|
|
Author keywords
Drug pipeline; Novel drug discovery approaches; Sepsis; Septic shock
|
|
Indexed keywords
3 BROMO 5 [N PHENYL N [2 [[2 (1,2,3,4 TETRAHYDRO 2 ISOQUINOLYLCARBONYLOXY)ETHYL]CARBAMOYL]ETHYL]CARBAMOYL] 1 PROPYLPYRIDINIUM NITRATE;
AFELIMOMAB;
ALKALINE PHOSPHATASE;
ANTITHROMBIN III;
CD14 ANTIGEN;
CENTOXIN;
CYTOFAB;
CYTOKINE RECEPTOR ANTAGONIST;
DROTRECOGIN;
E 5564;
EDOBACOMAB;
ENDOTOXIN ANTIBODY;
ERITORAN;
GINKGOLIDE B;
GR 270773;
HIGH MOBILITY GROUP B1 PROTEIN;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
LENERCEPT;
LEXIPAFANT;
LIPOPOLYSACCHARIDE;
MACROPHAGE MIGRATION INHIBITION FACTOR;
OPEBACAN;
PMX 622;
PROTEIN P75;
RECOMBINANT HUMAN ANTITHROMBIN III;
RECOMBINANT THROMBOMODULIN;
RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR;
RESATORVID;
TAK 242;
TENECRIN;
TOLL LIKE RECEPTOR 4;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
TUMOR NECROSIS FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VARESPLADIB;
DRUG EFFECT;
GRAM NEGATIVE SEPSIS;
HOST;
HUMAN;
NONHUMAN;
PATHOPHYSIOLOGY;
RESEARCH;
REVIEW;
SEPTIC SHOCK;
ANIMALS;
BACTERIA;
BLOOD COAGULATION;
CYTOKINES;
HUMANS;
INFLAMMATION MEDIATORS;
SEPSIS;
TERMINOLOGY;
|
|
EID: 33947653849
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (0)
|
